0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
India's pharma market grew by 8.4% in FY25, led by cardiac, gastro, and anti-diabetic segments, with key shifts from drug launches and patent expiries.
Share this article
If you liked this article share it with your friends.they will thank you later
/pratidin/media/media_files/2025/02/10/AtKfrSBhbSAMSXi61skn.jpg)
/pratidin/media/media_files/2025/04/09/8ejYtwo39kgfOtduynbo.jpg)
2 Min read
/pratidin/media/post_attachments/pratidintime/import/2019/09/gst.jpg)
/pratidin/media/agency_attachments/2024/11/06/2024-11-06t060101441z-pratidin-logo.png){kind=logo}
